title: Parkinsonism following neuroleptic exposure: A double-hit hypothesis?
abstract: Drug-induced parkinsonism is caused by an offending drug and should resolve after the causative agent has been withdrawn. However, in a number of patients, symptoms persist or may even worsen over time, suggesting the development of concomitant Parkinson's disease. The prevalence estimates of Parkinson's disease after neuroleptic exposure are unexpectedly high, suggesting a causal relationship. We critically review available literature in this regard, and some pathophysiological hypotheses that might explain such a relationship are suggested. Some patients may have an undetermined genetic susceptibility to parkinsonism. We speculate that the possible neurotoxic effect of neuroleptics exerted on a susceptible dopaminergic system would lead over the long-term to a self-fostering, progressive process. Knowledge gaps and future perspectives are discussed.
authors: Sobell Department of Motor Neuroscience and Movement Disorders, University College London (UCL) Institute of Neurology, London, United Kingdom.|Dipartimento di Scienze Neurologiche e del Movimento, Università di Verona, Italy.
authors: Roberto
authors: R
authors: Erro
authors: Sobell Department of Motor Neuroscience and Movement Disorders, University College London (UCL) Institute of Neurology, London, United Kingdom.
authors: Kailash P
authors: KP
authors: Bhatia
authors: Dipartimento di Scienze Neurologiche e del Movimento, Università di Verona, Italy.
authors: Michele
authors: M
authors: Tinazzi
mesh_terms: D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000633:toxicity*; D001921:Brain / Q000187:drug effects* / Q000503:physiopathology; D020022:Genetic Predisposition to Disease; D006801:Humans; D010300:Parkinson Disease / Q000453:epidemiology / Q000209:etiology* / Q000503:physiopathology; D010302:Parkinson Disease, Secondary / Q000139:chemically induced* / Q000503:physiopathology; D015995:Prevalence; D012307:Risk Factors; D013997:Time Factors
chemical_list: D014150:Antipsychotic Agents
keywords: Parkinson's disease; anti-pychotics; drug-induced parkinsonism; neuroleptics; pathophysiology